Abstract
Increased expression of PRKD1 and its gene product protein kinase D1 (PKD1) are linked to oncogenic signaling in pancreatic ductal adenocarcinoma, but a direct functional relationship to oncogenic KRas has not been established so far. We here describe the PRKD1 gene promoter as a target for oncogenic KRas signaling. We demonstrate that KRas-induced activation of the canonical NF-κB pathway is one mechanism of how PRKD1 expression is increased and identify the binding sites for NF-κB in the PRKD1 promoter. Altogether, these results describe a novel mechanism governing PRKD1 gene expression in PDA and provide a functional link between oncogenic KRas, NF-κB and expression of PRKD1.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Carcinoma, Pancreatic Ductal / genetics
-
Carcinoma, Pancreatic Ductal / metabolism*
-
Carcinoma, Pancreatic Ductal / pathology
-
Cell Line, Tumor
-
Gene Expression Regulation, Enzymologic*
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
NF-kappa B / genetics
-
NF-kappa B / metabolism*
-
Pancreatic Neoplasms / genetics
-
Pancreatic Neoplasms / metabolism*
-
Pancreatic Neoplasms / pathology
-
Promoter Regions, Genetic*
-
Protein Kinase C / biosynthesis*
-
Protein Kinase C / genetics
-
Proto-Oncogene Proteins p21(ras) / genetics
-
Proto-Oncogene Proteins p21(ras) / metabolism*
-
Signal Transduction*
Substances
-
KRAS protein, human
-
NF-kappa B
-
protein kinase D
-
Protein Kinase C
-
Proto-Oncogene Proteins p21(ras)